Page 22 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

India’s hopes to administer two billion doses of Covid-19 vaccines between August and December have received a boost with a new US-made vaccine to be produced in India by the Serum Institute showing high protective efficacy. The US-based vaccine maker Novavax announced on Monday that its protein-based Covid-19 vaccine has demonstrated 90.4 per cent efficacy against the novel coronavirus infection and 100 per cent efficacy against moderate and severe disease. Advertisement The vaccine also showed 93 per cent efficacy against predominantly circulating variants of concern (VoC) or variants of interest (VoI), the company added, reporting the results of a clinical trial on over 29,900 participants at 119 sites across the US and Mexico.

Czech republicUnited kingdomSouth koreaStanley erckShahid jameelSerum instituteTrivedi school of biosciences at ashoka universitySerum institute of indiaWorld health organisationPune based serum instituteTrivedi schoolWorld healthசெக் குடியரசுஒன்றுபட்டது கிஂக்டம்தெற்கு கொரியாஸ்டான்லி ஏற்க்க்